Detalhe da pesquisa
1.
Association between toothbrushing and cardiovascular risk factors: a cross-sectional study using Korean National Health and Nutrition Examination Survey 2015-2017.
BMC Oral Health
; 24(1): 4, 2024 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38167045
2.
Three-year clinical outcome of biodegradable hybrid polymer Orsiro sirolimus-eluting stent and the durable biocompatible polymer Resolute Integrity zotarolimus-eluting stent: A randomized controlled trial.
Catheter Cardiovasc Interv
; 96(7): 1399-1406, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31859438
3.
Improved oral hygiene care attenuates the cardiovascular risk of oral health disease: a population-based study from Korea.
Eur Heart J
; 40(14): 1138-1145, 2019 04 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30561631
4.
Long-Term Comparison of Platinum Chromium Everolimus-Eluting Stent vs. Cobalt Chromium Zotarolimus-Eluting Stentã- 3-Year Outcomes From the HOST-ASSURE Randomized Clinical Trial.
Circ J
; 83(7): 1489-1497, 2019 06 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-31155604
5.
Gelatin microgel-coated balloon catheter with enhanced delivery of everolimus for long-term vascular patency.
Acta Biomater
; 173: 314-324, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37949201
6.
BioMatrix Versus Orsiro Stents for Coronary Artery Disease: A Multicenter, Randomized, Open-Label Study.
Circ Cardiovasc Interv
; 16(1): e012307, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36475473
7.
BioMatrix versus Orsiro biodegradable polymer stents in all-comer patients with coronary artery disease: the multicentre, randomised BIODEGRADE trial.
EuroIntervention
; 16(17): 1404-1412, 2021 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32958459
8.
Intravascular imaging analysis of a drug-eluting balloon followed by a bare metal stent compared to a drug-eluting stent for treatment of de novo lesions.
Korean J Intern Med
; 34(4): 819-829, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29961306
9.
Angiographic outcomes of Orsiro biodegradable polymer sirolimus-eluting stents and Resolute Integrity durable polymer zotarolimus-eluting stents: results of the ORIENT trial.
EuroIntervention
; 12(13): 1623-1631, 2017 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28105994
10.
Harmonizing Optimal Strategy for Treatment of coronary artery diseases--comparison of REDUCtion of prasugrEl dose or POLYmer TECHnology in ACS patients (HOST-REDUCE-POLYTECH-ACS RCT): study protocol for a randomized controlled trial.
Trials
; 16: 409, 2015 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26374625
11.
A randomized comparison of platinum chromium-based everolimus-eluting stents versus cobalt chromium-based Zotarolimus-Eluting stents in all-comers receiving percutaneous coronary intervention: HOST-ASSURE (harmonizing optimal strategy for treatment of coronary artery stenosis-safety & effectiveness of drug-eluting stents & anti-platelet regimen), a randomized, controlled, noninferiority trial.
J Am Coll Cardiol
; 63(25 Pt A): 2805-16, 2014 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24814486
12.
The 'Harmonizing Optimal Strategy for Treatment of coronary artery stenosis - sAfety & effectiveneSS of drug-elUting stents & antiplatelet REgimen' (HOST-ASSURE) trial: study protocol for a randomized controlled trial.
Trials
; 13: 29, 2012 Mar 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-22463698